Prices delayed by at least 15 minutes | Print
Polar Capital Global Healthcare Trust PLC
ORD 25POpen
472.50p
Previous close
469.00p
Trade high
477.00p
Estimated NAV
465.921
Year high
488.00p
Year low
352.107p
Premium / Discount
0.66%
Market capitalisation
£516.73 mn
Volume
154,557
Dividend yield
0.47%
Ongoing charge
0.94%
ISIN
GB00B6832P16
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 06/02/2026 | 07/08/2026 |
| Ex-dividend date | 05/02/2026 | 06/08/2026 |
| Payment date | 27/02/2026 | 28/08/2026 |
| Amount | 1.00p | 1.20p |
Net asset value (NAV)
| Estimated NAV | 465.92 |
|---|---|
| Latest actual NAV | 465.87 |
| Latest actual NAV date | 12 November 2026 |
| 12m average premium/discount | 0.58% |
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Johnson & Johnson | 10.13 |
| Eli Lilly and Co | 9.83 |
| UnitedHealth Group Inc | 6.10 |
| Roche Holding AG Ordinary Shares new | 5.56 |
| Teva Pharmaceutical Industries Ltd | 4.85 |
| Abbott Laboratories | 4.35 |
| Danaher Corp | 4.31 |
| AstraZeneca PLC | 3.81 |
| Agilent Technologies Inc | 3.51 |
| IQVIA Holdings Inc | 3.25 |
Investment objective
The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks.The Company seeks to achieve this objective by investing in a diversified global portfolio consisting primarily of listed equities issued by healthcare companies involved in pharmaceuticals, medical services, medical devices and biotechnology. The portfolio is expected to be diversified by factors such as geography, industry sub-sector and investment size.
Morningstar ratingTM
Morningstar sustainability ratingTM
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 16/11/2026 | 12:04:05 | 475.48 | 208 | 989.00 |
| 16/11/2026 | 12:01:59 | 475.9 | 20,673 | 98,382.81 |
| 16/11/2026 | 11:57:02 | 474.82 | 53 | 251.65 |
| 16/11/2026 | 11:53:46 | 475.48 | 535 | 2,543.82 |
| 16/11/2026 | 11:49:54 | 475.48 | 124 | 589.60 |